Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11301399 | 1.00 | CYP2C19 (0.38) | CYP2C19FFAR3MMEAKR1C1USP2 | |
| SCHEMBL5513287 | 1.00 | CYP2C19 (0.38) | CYP2C19FFAR3MMEAKR1C1USP2 | |
| SCHEMBL5509879 | 1.00 | CYP2C19 (0.38) | CYP2C19FFAR3MMEAKR1C1USP2 | |
| SCHEMBL28284575 | 0.98 | CYP2C19 (0.37) | CYP2C19FFAR3MMEAKR1C1USP2 | |
| SCHEMBL3809509 | 0.97 | FFAR3 (0.38) | CYP2C19FFAR3MMEAKR1C1ALDH1A1 | |
| SCHEMBL4581131 | 0.92 | FFAR3 (0.38) | CYP2C19FFAR3ALDH1A1TSHR | |
| SCHEMBL3140773 | 0.87 | — | — | |
| SCHEMBL14037335 | 0.83 | FFAR3 (0.40) | CYP2C19FFAR3MMEAKR1C1USP2 | |
| SCHEMBL29000323 | 0.81 | CYP2C19 (0.35) | CYP2C19FFAR3MME | |
| SCHEMBL10532998 | 0.81 | CYP2C19 (0.35) | CYP2C19FFAR3MMEUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114790136-A | Preparation method and application of active trivalent organic chromium compound | 中国石油天然气股份有限公司 | 2022-07-26 | — | — | CN | claimed |
| EP-2047908-B1 | METHOD FOR PREPARING A HYDROGENATION CATALYST COMPOSITION AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2017-02-22 | — | — | EP | claimed |
| US-20130165686-A1 | Process for the Preparation of Nateglinide | CIPLA LIMITED (IN) | 2013-06-27 | — | — | US | claimed |
| EP-1765769-A1 | PROCESS FOR THE PREPARATION OF NATEGLINIDE | Cipla Ltd. (IN) | 2007-03-28 | — | — | EP | claimed |
| WO-2005121071-A1 | PROCESS FOR THE PREPARATION OF NATEGLINIDE | CIPLA LIMITED (IN) | 2005-12-22 | — | — | WO | claimed |
| US-11807764-B2 | Ink compositions, production method thereof, and method of forming quantum dot polymer composite pattern using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| CN-112637973-B | Long-life ceramic electric heater | 蚌埠市科达电器有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114790136-A | Preparation method and application of active trivalent organic chromium compound | 中国石油天然气股份有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-112594296-B | High-performance permanent magnet bistable electromagnetic clutch | 蚌埠市科达电器有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-112637973-A | Long-life ceramic electric heater | 蚌埠市科达电器有限公司 | 2021-04-09 | — | — | CN | disclosed |
| CN-112594296-A | High-performance permanent magnet bistable electromagnetic clutch | 蚌埠市科达电器有限公司 | 2021-04-02 | — | — | CN | disclosed |
| CN-109651129-A | A kind of 4- isopropyl cyclohexanecarboxylic acid turns structure and separation method along anti-mixture | 浙江清和新材料科技有限公司 | 2019-04-19 | — | — | CN | disclosed |
| US-4880937-A | REDUCING A CARBOXYLIC ACID OR ESTER, CATALYST | JAPAN TOBACCO, INC. (JP) | 1989-11-14 | — | — | US | disclosed |
| EP-0285786-A2 | Method of producing alcohols | Japan Tobacco Inc. (JP) | 1988-10-12 | — | — | EP | disclosed |
| EP-0230286-A2 | Method of synthesizing esters | Japan Tobacco Inc. (JP) | 1987-07-29 | — | — | EP | disclosed |
| US-4296093-A | Cyclic carboxamides having a physiological cooling effect | WILKINSON SWORD LIMITED (GB) | 1981-10-20 | — | — | US | disclosed |
| US-4283420-A | ANTICONVULSANTS, ANTIANAPHYLACTIC AGENTS, ANTIPSYCHOTIC AGENTS | LABAZ (FR) | 1981-08-11 | — | — | US | disclosed |
| US-4025401-A | Method for diaphragm electrolysis of alkali metal halides | MARUZEN OIL CO. LTD. (JA) | 1977-05-24 | — | — | US | disclosed |
| US-4011147-A | METHOD FOR DIAPHRAGM ELECTROLYSIS OF ALKALI METAL HALIDES | MARUZEN OIL CO. LTD. (JA) | 1977-03-08 | — | — | US | disclosed |
| US-3970534-A | Graft copolymer and process for preparation thereof | MARUZEN OIL CO. LTD. (JA) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165686-A1 | Process for the Preparation of Nateglinide | ANPEP, PREP, PTMA | CYP2C19 162/4885FFAR3 587/4885MME 251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.